| 0.6598 0 (0%) | 01-31 16:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Invacare Corporation, along with its affiliated entities, stands as a prominent international provider specializing in the design, production, distribution, and global export of medical devices. These products cater to diverse sectors, including home healthcare, retail environments, and long-term care facilities worldwide. Its extensive product portfolio encompasses mobility and seating solutions. These include power wheelchairs sold under the Invacare TDX brand, custom manual wheelchairs bearing the Invacare, Invacare Top End, and Küschall names, and various seating and positioning aids within the Invacare line. Furthermore, specialized custom molded seat modules are offered under the PinDot brand. Beyond mobility, Invacare supplies a range of daily living aids. This category features pressure-relieving overlays and mattress systems, such as the Invacare Softform and microAIR series; safe patient handling equipment like the Birdie, Evo, and ISA brands; and residential and institutional care beds along with their accessories, and certain manual wheelchairs, all primarily under the Invacare label. The company also provides personal care items. Additionally, the firm is a key supplier of respiratory therapy products. Its offerings here include stationary oxygen concentrators (Platinum, Perfecto2), portable oxygen concentrators (Platinum), and the Invacare HomeFill oxygen systems. In addition to manufacturing, Invacare provides essential services such as equipment repair and rentals, alongside external contracting. The company also acts as a distributor for supplementary health products, including heart rate monitors, thermometers, nebulizers, and portable ramps. Invacare distributes its offerings predominantly to home medical equipment providers, reaching them through both retail outlets and online platforms. It also serves residential care operators, dealers, and government health service customers, leveraging its internal sales teams, independent representatives, and a network of distributors. Established in 1885, Invacare Corporation maintains its headquarters in Elyria, Ohio.
Tue, 19 Nov 2024
Invacare Corp(IVC) price, News & Forecast - admiralmarkets.com
Mon, 08 May 2023
Invacare completes restructuring, emerges from Chapter 11 - MassDevice
Mon, 08 May 2023
Invacare Holdings Corporation Completes Financial Restructuring and is Well Positioned to Drive Forward in its Transformation - Business Wire
Fri, 24 Mar 2023
Here's how Invacare is thinking of its post-bankruptcy future - Crain's Cleveland Business
Mon, 01 Mar 2021
Invacare Corporation Introduces the Next Generation Alber e-motion® Power Assist Device - Business Wire
Tue, 01 Dec 2020
Invacare Stock Price Forecast. Should You Buy IVC? - StockInvest.us
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |